Literature DB >> 18215071

Nucleation, growth, and activation energies for seeded and unseeded aggregation of alpha-chymotrypsinogen A.

Jennifer M Andrews1, William F Weiss, Christopher J Roberts.   

Abstract

The intrinsic time scales for nonnative aggregate nucleation (tau0(n)) and chain growth (tau0(g)) were determined for alpha-chymotrypsinogen A as a function of temperature under acidic conditions where the resulting aggregates do not appreciably condense. Previous results (Andrews and Roberts (2007) Biochemistry 46, 7558) indicated that the product tau0(n)tau0(g) increases with increasing temperature but could not distinguish tau0(n) and tau0(g). Separate experimental values of tau0(n) and tau0(g) are reported here from two approaches based on either (i) combining unseeded monomer loss kinetics with static light scattering of the resulting aggregates or (ii) seeded monomer loss kinetics as a function of number concentration of seed. Values of tau0(n) and tau0(g) from (i) and (ii) agree quantitatively, and indicate that nucleation has a large, negative effective activation energy (ca. -76 kcal/mol) while growth has at most a weak dependence on temperature. The results are consistent with a model in which nucleation requires significant conformational changes within a nonnative oligomer, beyond those for monomer unfolding. The results more generally illustrate the potential utility of approaches (i) and (ii) for quantitatively determining in vitro tau0(n) and tau0(g) values, as well as how the effects of seeding can be predicted purely from unseeded kinetics and static light scattering measurements prior to significant aggregate condensation.

Mesh:

Substances:

Year:  2008        PMID: 18215071     DOI: 10.1021/bi7019244

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Predicting unfolding thermodynamics and stable intermediates for alanine-rich helical peptides with the aid of coarse-grained molecular simulation.

Authors:  Cesar Calero-Rubio; Bradford Paik; Xinqiao Jia; Kristi L Kiick; Christopher J Roberts
Journal:  Biophys Chem       Date:  2016-07-22       Impact factor: 2.352

2.  Mercury(II) binds to both of chymotrypsin's histidines, causing inhibition followed by irreversible denaturation/aggregation.

Authors:  Amanda Stratton; Matthew Ericksen; Travis V Harris; Nick Symmonds; Todd P Silverstein
Journal:  Protein Sci       Date:  2017-01-14       Impact factor: 6.725

3.  Protein-protein interactions controlling interfacial aggregation of rhIL-1ra are not described by simple colloid models.

Authors:  Lea L Sorret; Madison A DeWinter; Daniel K Schwartz; Theodore W Randolph
Journal:  Protein Sci       Date:  2018-03-03       Impact factor: 6.725

4.  Parallel chromatography and in situ scattering to interrogate competing protein aggregation pathways.

Authors:  Diana Gomes; Rebecca K Kalman; Rebecca K Pagels; Miguel A Rodrigues; Christopher J Roberts
Journal:  Protein Sci       Date:  2018-06-13       Impact factor: 6.725

Review 5.  Therapeutic protein aggregation: mechanisms, design, and control.

Authors:  Christopher J Roberts
Journal:  Trends Biotechnol       Date:  2014-06-04       Impact factor: 19.536

6.  Lumry-Eyring nucleated-polymerization model of protein aggregation kinetics. 2. Competing growth via condensation and chain polymerization.

Authors:  Yi Li; Christopher J Roberts
Journal:  J Phys Chem B       Date:  2009-05-14       Impact factor: 2.991

7.  Reduction of the C191-C220 disulfide of α-chymotrypsinogen A reduces nucleation barriers for aggregation.

Authors:  William F Weiss; Aming Zhang; Magdalena I Ivanova; Erinc Sahin; Jacob L Jordan; Erik J Fernandez; Christopher J Roberts
Journal:  Biophys Chem       Date:  2013-11-28       Impact factor: 2.352

8.  Connecting high-temperature and low-temperature protein stability and aggregation.

Authors:  Mónica Rosa; Christopher J Roberts; Miguel A Rodrigues
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

9.  Protein-protein interactions in dilute to concentrated solutions: α-chymotrypsinogen in acidic conditions.

Authors:  Marco A Blanco; Tatiana Perevozchikova; Vincenzo Martorana; Mauro Manno; Christopher J Roberts
Journal:  J Phys Chem B       Date:  2014-05-21       Impact factor: 2.991

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.